ISPOR 14th Annual International Meeting Awards Recipients
Stephen L. Priori, Director, ISPOR Publications
At the ISPOR Fourteenth Annual International Meeting, May 16-20, 2009, Renaissance Orlando Resort at SeaWorld, Orlando, FL, USA, the ISPOR Awards Committee, chaired by Fadia Shaya PhD, recognized recipients of ISPOR Research Excellence Awards, Contributed Research Awards and Distinguished Service Awards.
The Seventh ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award
The ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award was established in honor of the late Avedis Donabedian MD. Dr. Donabedian was a renowned faculty member of the University of Michigan, School of Public Health who dedicated his life to improving the quality of health care and health care systems. After a long process that involved nominations, selection of a panel of finalists, the ISPOR Lifetime Achievement Awards Committee, Chaired by Sean Sullivan PhD, selected the recipient:
 Milton C. Weinstein PhD, Professor Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
A special thanks to Sean Sullivan PhD and the Avedis Donabedian Outcomes Research Lifetime Achievement Award Committee for their efforts!
2009 ISPOR Bernie J. O’Brien New Investigator Award
The ISPOR Bernie O’Brien New Investigator Award was established in 2004 to honor the long-standing commitment of Bernie J. O’Brien, PhD to training and mentoring new scientists in the fields of outcomes research and pharmacoeconomics. The ISPOR Bernie J. O’Brien New Investigator Award Committee, chaired by Shelby Reed PhD, RPh, selected the recipient:
 Anirban Basu PhD, Assistant Professor, University of Chicago, Chicago, IL, USA
A special thanks to Shelby Reed PhD, RPh, and the Bernie O’Brien New Investigator Award Committee for their efforts!
2009 ISPOR Research Excellence Awards
The recipients of the 2009 ISPOR Research Excellence Award (one for Methodology Excellence and one for Application Excellence) are selected by the Awards Committee based upon publications that have appeared in respected peer-review journals and other communication venues (e.g., books, reports) during the preceding 12 months from January 1 of the year awarded. The award selection is based upon the publication’s clear description of methods, along with the appropriate and creative applications (or proposal thereof in conceptual methodology work) of techniques to answer important questions in the field of pharmacoeconomics and outcomes research. Such publications will be expected to have much impact on the field, due to their acceptance and application by others.
The 2009 recipient of the ISPOR Award for Excellence in Methodology in Pharmacoeconomics and Health Outcomes Research is:
 Mandy Ryan PhD, Professor in Health Economics, University of Aberdeen, Aberdeen, UK, as the senior author of the research paper: “Rationalising the ‘Irrational’: A Think Aloud Study Of Discrete Choice Experiment Responses” Health Economics 2009;18:321-36.
The 2009 recipient of the ISPOR Award for Excellence in Application of Pharmacoeconomics and Health Outcomes Research is:
 Maureen Rutten-van Mölken PhD, Associate Professor Health Economics-Institute for Medical Technology Assessment, Erasmus University/Erasmus Medical Centre, Rotterdam, The Netherlands, as senior author of the research paper: “Expected Value of Perfect Information: An Empirical Example of Reducing Decision Uncertainty by Conducting Additional Research” Value in Health 2008;11:1070-80. (Both Dr. Ryan and Dr. Rutten-van Mölken will be presented their awards at the 12th Annual European Congress in Paris, France)
A Special thanks to Rajesh Balkrishnan PhD MS, Chair, ISPOR Research Excellence Award in Methodological Excellence and Jalpa Doshi, PhD, Chair, ISPOR Research Excellence Award in Practical Application Excellence and their Committees for selecting the recipients!
14th Annual International Meeting Research Presentation Awards
The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, Asia-Pacific and Latin America Conferences.
This year, the ISPOR judges evaluated over 80 podium presentations and over 100 nominated poster presentations. All podium presentations are considered for an award. Poster presentations in the top 20%, based on abstract review score, are considered and eligible for a poster presentation award.
Evaluations of scientific merit were based upon the following criteria:
• Background provides appropriate perspective / context for the subject
• Objectives / research questions are clearly stated
• Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
• Data sources and/or sampling procedures are clear and appropriate
• Data analyses are appropriate
• Research objectives are met/addressed
• Implications of findings are discussed
• Factual information is kept separate from interpretations or implications
• Abstract is presented in an unbiased manner
• Clarity of presentation
A special thanks goes to Elizabeth Manias PhD, RPh, Chair, ISPOR Podium and Poster Research Presentation Awards Committee -- Podium Research Presentations, AS WELL AS TO David Thompson PhD, Chair, ISPOR Podium and Poster Research Presentation Awards Committee -- Poster Research Presentations, for all their efforts in selecting the recipients!
And the recipients are...
Best Podium Research Presentations
MO4 - RE-EXAMINING THE SPECIFICATION OF REGRESSION MODELS OF MULTINOMIAL RESPONSES: AN APPLICATION TO PREDICTING POST-STROKE DISCHARGE DISPOSITION
Bergtold J1, Onukwugha E2 1Kansas State University, Manhattan, KS, USA, 2University of Maryland School of Pharmacy, Baltimore, MD, USA
|
QL4 - VALIDATION OF THE TREATMENT RELATED IMPACT MEASURE FOR DIABETES TREATMENT AND DEVICE; TRIM-DIABETES AND TRIM-DIABETES DEVICE
Brod M1, Hammer M2, Christensen T2, Bushnell D3 1The BROD GROUP, Mill Valley, CA, USA, 2Novo Nordisk A/S, Bagsværd, Denmark, 3Health Research Associates, Inc, Mountlake Terrace, WA, USA
|
HM1 - EFFICIENCY AND ECONOMIC BENEFITS ASSOCIATED WITH THE USE OF A PAYER-BASED ELECTRONIC HEALTH RECORD IN AN EMERGENCY DEPARTMENT AMONG A HEALTH INSURED POPULATION
Daniel GW1, Ewen E2, Willey VJ3, Shirazi M4, Malone DC5 1HealthCore, Wilmington, DE, USA, 2Christiana Care Health System, Newark, DE, USA, 3University of the Sciences in Philadelphia, Philadelphia, PA, USA, 4University of Arizona College of Medicine, Tucson, AZ, USA, 5University of Arizona College of Pharmacy, Tucson, AZ, USA |
Best New Investigator Podium Presentations
PM3 - USE OF PHARMACOGENETIC TESTING TO DETERMINE ADJUVANT HORMONAL THERAPY CHOICE IN EARLY STAGE BREAST CANCER PATIENTS: A VALUE OF INFORMATION ANALYSIS
Woods BS, Hawkins NS
Oxford Outcomes (UK), Oxford, UK |
CM3 - THE IMPACT OF MEDICARE PART D ON ELDERLY PATIENTS' COMPLIANCE WITH STATINS
Zhang D, Henderson SC, Denarie MF
IMS Health, Blue Bell, PA, USA |
ND3 - PRESCRIBING PATTERNS AMONG DEMENTIA PATIENTS AT THE VETERANS AFFAIRS MARYLAND HEALTH CARE SYSTEM (VAMHCS)
Rattinger GB1, DeLisle S2, Onukwugha E1, Mullins CD1
1University of Maryland School of Pharmacy, Baltimore, MD, USA, 2University of Maryland School of Medicine and VA Maryland Health Care System, Baltimore, MD, USA |
Best Student Podium Presentations
VA1 - A MARKOV MODEL EXAMINING THE PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF MASS VACCINATION USING LIVE ATTENUATED HUMAN ROTAVIRUS VACCINE IN A DEVELOPING ASIAN COUNTRY
Rose J1, Molnar RL1, Watts B2, Singer ME1
1Case Western Reserve University School of Medicine, Cleveland, OH, USA, 2Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH, USA |
DU2 - RACIAL DISPARITIES AND BARRIER TO DRUG UTILIZATION IN PATIENTS WITH DIABETES IN THE UNITED STATES
Seetasith A, Zhang JX
Virginia Commonwealth University, Richmond, VA, USA |
CV2 - COMPARISON OF CARDIOVASCULAR EVENT RATES IN SUBJECTS WITH TYPE-2 DIABETES MELLITUS WHO AUGMENTED FROM STATIN MONOTHERAPY TO STATIN PLUS FIBRATE COMBINATION THERAPY WITH THOSE WHO REMAINED ON STATIN MONOTHERAPY
Suh HS, Doctor JN
University of Southern California, Los Angeles, CA, USA |
Best Poster Research Presentation
PMH38 - THE ECONOMIC IMPACT OF GENERIC SWITCHING FOR PATIENTS WITH MAJOR DESPRESSIVE DISORDER (MDD) TREATED WITH ESCITALOPRAM OR A PATENTED SSRI
Lauzon V1, Kaltenboek A2, Yu AP2, Ramakrishnan K2, Marynchenko M1, Wu EQ2, Ben-Hamadi R2, Erder MH3, Bose A3 1Analysis Group, Inc., Montreal, QC, Canada, 2Analysis Group, Inc., Boston, MA, USA, 3Forest Research Institute, Jersey City, NJ, USA |
PCN24 - THE ECONOMIC IMPLICATIONS OF RASBURICASE TREATMENT IN ADULT TUMOR LYSIS SYNDROME PATIENTS
Eaddy M1, Seal B2, Tangirala M3, O'Day K1
1Xcenda, Palm Harbor, FL, USA, 2Sanofi-Aventis, Bridgewater, NJ, USA, 3Smith Hanley Consulting Group LLC, Lake Mary, FL, USA
|
PDB10 - A COMPARISON OF ECONOMIC OUTCOMES BETWEEN ADHERENT AND NONADHERENT PATIENTS TREATED WITH ORAL ANTIDIABETIC MEDICATIONS Hansen RA1, Farley JF1, Droege M2, Maciejewski ML3
1University of North Carolina, Chapel Hill, NC, USA, 2Takeda Pharmaceuticals North America, Inc, Deerfield, IL, USA, 3Center for Health Services Research in Primary Care, Durham, NC, USA |
Best New Investigator Poster Research Presentations
PCN105 - GUIDELINES AND CANCER SCREENING IN THE UNITED STATES AND CANADIAN HEALTH SYSTEMS
Kadiyala S1, Strumpf EC2
1University of Washington, Seattle, WA, USA, 2McGill University, Monreal, QC, Canada |
PMS18 - ESTIMATION OF COSTS RELATED TO ADVERSE EVENTS IN NSAID TREATMENT OF OSTEOARTHRITIS – A COMPARISON BETWEEN CELECOXIB AND IBUPROFEN USING A VALIDATED MODEL
Svedbom A1, Borgstrom F1, Holmstrom S2, Miltenburger C3
1i3 Innovus, Stockholm, Sweden, 2NicOx, Sophia Antipolis, France, 3i3 Innovus, Berlin, Germany
|
PCV35 - PHARMACOECONOMIC MODEL OF ENOXAPARIN VERSUS HEPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM IN MEDICAL PATIENTS Milani-Jr R1, Follador W2, Gonçalves J2, Di Sena V2
1São Paulo University, São Paulo, São Paulo, Brazil, 2Sanofi-Aventis, São Paulo, São Paulo, Brazi
|
Best Student Poster Presentations
PMC51 - TESTING THE ROLE OF TIME IN AFFECTING THE UNIDIMENSIONALITY IN EQ-5D USING THE 2002-2003 MEDICAL EXPENDITURE PANEL SURVEY (MEPS): A FACETS MODEL APPROACH
Gu NY, Doctor JN University of Southern California, Los Angeles, CA, USA |
PCV24 - DAILY ALCOHOL CONSUMPTION AND RACE/ETHNICITY: THEIR RELATIONSHIP TO STROKE OR CORONARY ARTERY DISEASE IN THE US ADULT POPULATION
Becker TL, Campbell HM
Department of Veterans Affairs Cooperative Studies Program, Albuquerque, NM, USA
|
PSY11 - ESTIMATION OF CAUSAL EFFECTS OF PHYSICAL ACTIVITY ON OBESITY BY A RECURSIVE BIVARIATE PROBIT MODEL
Kawatkar AA, Nichol MB
University of Southern California, Los Angeles, CA, USA
|
ISPOR would like to thank all the judges who have volunteered their time and efforts during the meeting to score podium and poster research presentations.
ISPOR SERVICE AWARDEES
The ISPOR Service Awards recognize members who have served on the ISPOR Board of Directors or have significantly contributed to the vision and mission of the Society.
ISPOR 2006 – 2008 BOARD OF DIRECTORS SERVICE AWARDEES
PRESIDENT (2007-2008) & PAST PRESIDENT (2008-2009) Diana Brixner PhD, Professor & Executive Director, Pharmacotherapy Outcomes Research Center University of Utah College of Pharmacy, Salt lake City, UT, USA
DIRECTOR (2007-2009) Lou Garrison PhD, Pharmacotherapy Outcomes Research Center, Department of Pharmacy, University of Washington, Seattle, WA,USA
DIRECTOR (2007-2009) Richard Willke PhD, Senior Director, Head of CV/Metabolic, Urology and Respiratory Outcomes Research, Pfizer, Peapack, NJ, USA ISPOR DISTINGUISHED SERVICE AWARDEES
FOURTEENTH ANNUAL INTERNATIONAL MEETING PROGRAM CHAIR John Hornberger MD, MS, Principal, CEDAR Associates LLC and Adjunct Clinical Professor of Medicine, Stanford University School of Medicine, Menlo Park, CA, USA
VALUE IN HEALTH CO-EDITOR Sean D. Sullivan PhD, Professor and Director, University of Washington, Department of Pharmacy, University of Washington, Pharmaceutical Outcomes Research and Policy Program, Seattle, WA, USA
ISPOR MEDICATION COMPLIANCE & PERSISTENCE SPECIAL INTEREST GROUP CHAIR Dyfrig Hughes PhD, MRPharmS, Reader in Pharmacoeconomics and Deputy Director, Centre for Economics and Policy in Health, IMSCaR, Bangor University, Gwynedd, UK
ISPOR TRANSFERABILITY OF ECONOMIC DATA TASK FORCE CHAIR Michael Drummond PhD, Professor of Health Economics, University of York Centre for health Economics, York, UK
ISPOR PATIENT REPORTED OUTCOMES (PRO) TASK FORCE: USE OF EXISTING INSTRUMENTS AND THEIR MODIFICATION CHAIR Margaret Rothman PhD, Executive Director, WW Patient-reported Outcomes Center of Excellence, Johnson & Johnson Pharmaceutical Services, LLC, Washington, GA, USA
ISPOR GOOD RESEARCH PRACTICES FOR RETROSPECTIVE DATABASE ANALYSIS TASK FORCE CHAIR Michael Johnson PhD, Associate Professor University of Houston, College of Pharmacy, Houston, TX, USA
ISPOR DRUG COSTS STANDARDS TASK FORCE CO-CHAIRS James Smeeding RPh, MBA, President, JestaRx Group, Dallas, TX, USA
Joel Hay PhD, Professor, USC Dept. of Clinical Pharmacy, Pharmaceutical Economics & Policy, Los Angeles, CA, USA
ISPOR QUALITY IMPROVEMENT OF COST EFFECTIVENESS RESEARCH TASK FORCE CHAIR William McGhan PharmD, PhD, Professor of Pharmacy and Health Policy, University of the Sciences in Philadelphia, Philadelphia, PA, US
ISPOR STUDENT AWARDS
ISPOR STUDENT CHAPTER PRESIDENTS
The following students served as 2008-2009 President of the Student Council or 2008-2009 President of the ISPOR Student Chapter at the university indicated below:
STUDENT NETWORK CHAIR (2008-2009)
Caitlyn Wilke MS, University of Illinois at Chicago, Chicago, IL, USA
McMaster University-Chapter President
Ilia L. Ferrusi PhD
West Virginia University-Chapter President
Kimberly B. Blake PharmD, MBA
University of Arizona-Chapter President
Eleanor L. Olvey PharmD
University of Georgia-Chapter President
April Chapman
University of Southern California-Chapter President
Adam Turpcu
University of Tennessee, Memphis-Chapter President
Arijit Ganguli MBA
University of Texas, Austin-Chapter President
Millidhashni Reddy MParm
Ohio State University-Chapter President
Meg C. Kong MS
Purdue University-Chapter President
Engels N. Obi MS
Thomas Jefferson University-Chapter President
Safiya Abouzaid PharmD
University of Illinois, Chicago-Chapter President
Jay Duhig MA
University of Louisiana, Monroe-Chapter President
Vijay veer Bonthapally
University of Minnesota-Chapter President
Yan-wen Chen
University of Texas-Chapter President
Kavita Sail
University of Utah-Chapter President
Richard E. Nelson PhD
University of Maryland-Chapter President
Zhiqiang Lu BPharm
University of Southern California - ISPOR Student Network Newsletter Committee
Jerry Y. Chang PharmD
OUTSTANDING ISPOR STUDENT CHAPTER OF THE YEAR AWARD
The Outstanding ISPOR Student Chapter of the Year Award was established in 2007 to recognize ISPOR Student Chapters, which provide exemplary service to its university.
AWARD RECIPIENTS:
First Prize: University of Southern California, Los Angeles, CA., USA Second Prize: West Virginia University, Morgantown, WV, USA Third Prize: University of Texas, Austin, TX, USA
STUDENT TRAVEL GRANT AWARDS ISPOR
Student Travel Grant Awards provide selected students with an opportunity to attend the ISPOR Annual International Meeting.
STUDENT TRAVEL GRANT RECIPIENTS:
Minghui Li
China Pharmaceutical University, China
David Wu
National Yang-Ming University, Taiwan
Ashutosh Sanjay Gupta
NIPER, India
Liaquat Khwaja
Aga Khan University, Pakistan
Amir Zargarzadeh
Western University of Health Sciences, USA
SPONSORS:
ISPOR
STUDENT RESEARCH COMPETITION
Students competed in the second annual Student Research Competition at the ISPOR 14th Annual International Meeting. Questions were based on the Health Care Costs, Quality, and Outcomes; ISPOR Book of Terms.
STUDENT RESEARCH COMPETITION RECIPIENTS
First: West Virginia University
Second: National University of Singapore/China Pharmaceutical University/ Yang-Ming University (Taiwan)
Third: Univeristy of Washington
|
